Latest news with #LauraYecies
Business Journals
09-05-2025
- Health
- Business Journals
Bone Health Technologies launches OsteoBoost vibrating belt to combat loss of bone density
From the San Francisco Business Times. One of the most debilitating and potentially deadly effects of aging is the loss of bone density, but a Bay Area startup has launched a unique device that a study showed can help slow that process. Called OsteoBoost, the device is a vibrating belt that sends "low-amplitude, high-frequency" vibrations to the hips and spine, according to a de novo approval that the Food and Drug Administration that was granted early last year. The belt is designed for postmenopausal women with low bone density, or osteopenia — a precursor to osteoporosis — and can be worn throughout the day without impeding normal daily activities like walking. The startup was developed by Redwood City-based Bone Health Technologies, a startup that was spun out of a San Francisco-based medical device incubator called TheraNova in 2018. It's one of a handful of companies focused on addressing women's health issues, and has raised $11 million from investors including Esplanade Ventures, Berkeley Catalyst Fund and Terumo Medical. Although bone density loss affects all bodies, women are particularly vulnerable due to the impact of menopause, which causes accelerated aging from the rapid decline of the hormone estrogen. Around one-third of people older than 50 are estimated to have osteopenia in the U.S., according to the Cleveland Clinic. "You look in the App Store, for instance, under osteoporosis, there's not much there compared to diabetes or depression or high blood pressure, which, of course, are also very important," Bone Health CEO Laura Yecies said. "I believe this deserves that level of attention, and we shouldn't just accept that older women get frail."
Business Wire
07-05-2025
- Health
- Business Wire
Osteoboost Health Launches FDA-Cleared Prescription Wearable Device for Low Bone Density, Filling Critical Treatment Gap for 60M+ Americans
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Osteoboost Health, Inc. today announced the nationwide availability of Osteoboost, the first and only FDA-cleared prescription medical device for low bone density. Osteoboost is a brand-new wearable that bridges the gap between next-generation consumer health technology and rigorously tested medical innovation. Designed for effortless, at-home use, this clinically proven device delivers targeted vibration therapy directly to the spine and hips: areas at high risk for osteoporotic fractures. Osteoboost CEO Laura Yecie s said, 'Osteoboost empowers people to lead longer, stronger, and more active lives. While the belt is sophisticated medical technology rigorously tested and validated for efficacy, the treatment is easy - 30 minutes a day of vibration therapy that can be done while walking, or other activities.' A gold-standard, double-blinded, placebo-controlled clinical trial at the University of Nebraska Medical Center demonstrated that Osteoboost slowed bone density and strength loss in postmenopausal women with osteopenia who used it at least 3 times per week: 85% reduction in the loss of bone density in the spine 83% reduction in the loss of bone strength in the spine 55% reduction in the loss of bone density in the hip 'It's been a long time since we've seen any innovation for bone health, and yet every day I see patients terrified of the risks they face just walking down the street,' said Dr. Yevgeniya Kushchaeva, Clinical Director of University of South Florida Health Adult Endocrinology, and Medical Director of Adult Osteoporosis Program. 'Osteoboost did this the right way. They spent years investing in the clinical trial and FDA approval processes - not easy even for larger pharmaceutical companies.' Osteoboost also announced new strategic investments from AARP, Harvard Business School Angels, and She's Independent, plus a follow-on investment from Esplanade Healthtech Ventures. Osteoboost is a medical technology company developing non-invasive, and science-backed solutions for people with low bone density. For more information, including Instructions for Use, visit
